These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28791668)

  • 1. Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment.
    Xu T; Sheng Z; Yao L
    Front Med; 2017 Sep; 11(3):340-348. PubMed ID: 28791668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fatty Kidney: Obesity and Renal Disease.
    Praga M; Morales E
    Nephron; 2017; 136(4):273-276. PubMed ID: 27414023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.
    D'Agati VD; Chagnac A; de Vries AP; Levi M; Porrini E; Herman-Edelstein M; Praga M
    Nat Rev Nephrol; 2016 Aug; 12(8):453-71. PubMed ID: 27263398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity-related glomerulopathy: an emerging epidemic.
    Kambham N; Markowitz GS; Valeri AM; Lin J; D'Agati VD
    Kidney Int; 2001 Apr; 59(4):1498-509. PubMed ID: 11260414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity-related glomerulopathy and the nephron complement.
    Tsuboi N; Utsunomiya Y; Hosoya T
    Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv108-13. PubMed ID: 23868145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which Patients with Obesity Are at Risk for Renal Disease?
    Sandino J; Luzardo L; Morales E; Praga M
    Nephron; 2021; 145(6):595-603. PubMed ID: 33677441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity-Related Glomerulopathy: A Latent Change in Obesity Requiring More Attention.
    Yang S; Cao C; Deng T; Zhou Z
    Kidney Blood Press Res; 2020; 45(4):510-522. PubMed ID: 32498064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.
    Darouich S; Goucha R; Jaafoura MH; Zekri S; Ben Maiz H; Kheder A
    Ultrastruct Pathol; 2011 Aug; 35(4):176-82. PubMed ID: 21657818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Overweight and obesity--risk factors in the development and progression of renal disease].
    Sebeková K; Klassen A; Bahner U; Heidland A
    Vnitr Lek; 2004 Jul; 50(7):544-9. PubMed ID: 15323263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The importance of overweight and obesity for the development and progression of renal diseases].
    Klassen A; Bahner U; Sebekova K; Heidland A
    Dtsch Med Wochenschr; 2004 Mar; 129(11):579-82. PubMed ID: 14997412
    [No Abstract]   [Full Text] [Related]  

  • 11. Obesity-related glomerulopathy in China: a case series of 90 patients.
    Chen HM; Li SJ; Chen HP; Wang QW; Li LS; Liu ZH
    Am J Kidney Dis; 2008 Jul; 52(1):58-65. PubMed ID: 18423814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal disease in obesity: the need for greater attention.
    Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
    J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and chronic kidney disease.
    Eknoyan G
    Nefrologia; 2011; 31(4):397-403. PubMed ID: 21623393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Renal Pathology of Obesity: Structure-Function Correlations.
    Tsuboi N; Okabayashi Y
    Semin Nephrol; 2021 Jul; 41(4):296-306. PubMed ID: 34715960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and chronic kidney disease.
    Jiang Z; Wang Y; Zhao X; Cui H; Han M; Ren X; Gang X; Wang G
    Am J Physiol Endocrinol Metab; 2023 Jan; 324(1):E24-E41. PubMed ID: 36383637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of kidney biopsy findings in patients with morbid obesity.
    Choung HG; Bomback AS; Stokes MB; Santoriello D; Campenot ES; Batal I; Markowitz GS; D'Agati VD
    Kidney Int; 2019 Mar; 95(3):647-654. PubMed ID: 30712921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney disease in patients with obesity: It is not always obesity-related glomerulopathy alone.
    Salvatore SP; Chevalier JM; Kuo SF; Audia PF; Seshan SV
    Obes Res Clin Pract; 2017; 11(5):597-606. PubMed ID: 28442280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the use of glomerulomegaly as a surrogate marker of glomerular damage and for alpha-linolenic acid-rich oils in the treatment of early obesity-related glomerulopathy in a diet-induced rodent model of obesity.
    Caligiuri SP; Blydt-Hansen T; Love K; Grégoire M; Taylor CG; Zahradka P; Aukema HM
    Appl Physiol Nutr Metab; 2014 Aug; 39(8):951-9. PubMed ID: 24927777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sickle cell glomerulopathy with focal segmental glomerulosclerosis.
    Verani RR; Conley SB
    Child Nephrol Urol; 1991; 11(4):206-8. PubMed ID: 1777902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity-related glomerulopathy: body mass index and proteinuria.
    Shen WW; Chen HM; Chen H; Xu F; Li LS; Liu ZH
    Clin J Am Soc Nephrol; 2010 Aug; 5(8):1401-9. PubMed ID: 20498244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.